More about

Baylor University

News
January 31, 2023
2 min read
Save

BLOG: Creating systemic change with the ASTCT-NMDP ACCESS Initiative

BLOG: Creating systemic change with the ASTCT-NMDP ACCESS Initiative

“With great power comes great responsibility.”

News
December 21, 2022
2 min read
Save

COVID-19 pandemic reduced access to optimal lupus care, providers report

COVID-19 pandemic reduced access to optimal lupus care, providers report

Health care professionals around the world are reporting that the COVID-19 pandemic has prevented patients with systemic lupus erythematosus from receiving optimal care, resulting in increased risk for organ damage, according to a survey.

News
October 19, 2022
2 min read
Save

Continuous glucose monitoring use increasing among young people, linked to lower HbA1c

Continuous glucose monitoring use increasing among young people, linked to lower HbA1c

Use of continuous glucose monitoring among children and young adults with type 1 diabetes nearly doubled from 2017 to 2020 in the U.S. from 25% to 49% and was associated with lower HbA1c for users vs. non-users, according to registry data.

News
June 13, 2022
5 min watch
Save

VIDEO: Researchers discuss increased organ offers, workload for liver, kidney allocation

VIDEO: Researchers discuss increased organ offers, workload for liver, kidney allocation

Between 2019 and 2021, organ offers and workload over time for liver and kidney allocation increased significantly, according to findings presented at the American Transplant Congress.

News
August 27, 2021
3 min read
Save

Ejection fraction influences major renal event risk with empagliflozin

Ejection fraction influences major renal event risk with empagliflozin

The SGLT2 inhibitor empagliflozin decreased risk for major renal outcomes in patients with heart failure with reduced ejection fraction but not preserved ejection fraction, according to an analysis of two large randomized controlled trials.

News
August 13, 2021
3 min read
Save

Lung disease in RA filled with 'bad players'

Lung disease in RA filled with 'bad players'

A wide array of potential etiologies can cause lung disease in rheumatoid arthritis patients, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

News
July 27, 2021
2 min read
Save

FDA approves Keytruda for high-risk, early-stage triple-negative breast cancer

FDA approves Keytruda for high-risk, early-stage triple-negative breast cancer

The FDA approved pembrolizumab for treatment of patients with high-risk, early-stage triple-negative breast cancer.

News
May 20, 2021
2 min read
Save

FDA approves Opdivo for esophageal, gastroesophageal junction cancers

FDA approves Opdivo for esophageal, gastroesophageal junction cancers

The FDA approved nivolumab as adjuvant treatment for certain patients with completely resected esophageal or gastroesophageal junction cancers, according to the agent’s manufacturer.

News
December 14, 2020
3 min read
Save

Tesetaxel-capecitabine may provide all-oral option for metastatic breast cancer subset

Tesetaxel-capecitabine may provide all-oral option for metastatic breast cancer subset

The addition of tesetaxel to reduced-dose capecitabine improved PFS among women with HER2-negative, hormone receptor-positive metastatic breast cancer, according to study results presented at the virtual San Antonio Breast Cancer Symposium.

News
September 29, 2020
4 min read
Save

Nivolumab may be ‘new standard’ in esophageal, gastroesophageal junction cancers

Nivolumab may be ‘new standard’ in esophageal, gastroesophageal junction cancers

Adjuvant nivolumab significantly prolonged DFS compared with placebo among patients with resected esophageal and gastroesophageal junction cancer, according to results of the CheckMate 577 trial presented during ESMO Virtual Congress 2020.

View more